Aligos Therapeutics, Inc.
ALGS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001799448
No open-market purchases or sales by Aligos Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.2M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q1 2026
Institutional positions in Aligos Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −4 vs. Q4 2025
- Shares held
- 2.78M
- +164.8K (+6.3%) vs. Q4 2025
- Total value
- $20.6M
- −$3.70M (−15.2%) vs. Q4 2025
- New holders
- 7
- 8 more added
- Sold out
- 11
- 9 more reduced
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALGS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $13.2M |
| Q1 2026 | 35 | $20.6M |
| Q4 2025 | 41 | $26.2M |
| Q3 2025 | 33 | $26.0M |
| Q2 2025 | 37 | $19.5M |
| Q1 2025 | 35 | $27.1M |
| Q4 2024 | 34 | $64.5M |
| Q3 2024 | 27 | $14.7M |
| Q2 2024 | 49 | $16.6M |
| Q1 2024 | 49 | $45.3M |
| Q4 2023 | 40 | $30.1M |
| Q3 2023 | 36 | $19.2M |
| Q2 2023 | 41 | $25.5M |
| Q1 2023 | 46 | $23.9M |
| Q4 2022 | 39 | $25.3M |
| Q3 2022 | 52 | $30.4M |
| Q2 2022 | 60 | $36.0M |
| Q1 2022 | 76 | $68.4M |
| Q4 2021 | 71 | $390.4M |
| Q3 2021 | 68 | $483.9M |
| Q2 2021 | 58 | $550.5M |
| Q1 2021 | 52 | $612.4M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Aligos Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BNP Paribas Arbitrage, SA | 3 | $22 | 0.00% | 00.0% | Unchanged |
| ZRC Wealth Management, LLC | 4 | $30 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 26 | $193 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 65 | $483 | 0.00% | +26+66.7% | Added |
| Fortitude Family Office, LLC | 68 | $505 | 0.00% | +68 | New |
| Morgan Stanley | 218 | $1.62K | 0.00% | −2,302−91.3% | Reduced |
| JPMorgan Chase & Co | 674 | $4.42K | 0.00% | +368+120.3% | Added |
| Wells Fargo & Company | 700 | $5.20K | 0.00% | −800−53.3% | Reduced |
| Vanguard Global Advisers, LLC | 936 | $6.95K | 0.00% | +936 | New |
| Federation des caisses Desjardins du Quebec | 950 | $7.06K | 0.00% | +950 | New |
| Royal Bank of Canada | 2,125 | $16.0K | 0.00% | 00.0% | Unchanged |
| Golden State Wealth Management, LLC | 2,674 | $19.9K | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 10,000 | $74.3K | 0.00% | 00.0% | Unchanged |
| Quadrature Capital Ltd | 10,822 | $80.4K | 0.00% | +10,822 | New |
| D. E. Shaw & Co., Inc. | 10,978 | $81.6K | 0.00% | +10,978 | New |
| BlackRock, Inc. | 13,040 | $96.9K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 14,196 | $105.5K | 0.00% | −8,857−38.4% | Reduced |
| Verition Fund Management LLC | 18,887 | $140.3K | 0.00% | −52,367−73.5% | Reduced |
| Two Sigma Investments, LP | 23,093 | $171.6K | 0.00% | −57,556−71.4% | Reduced |
| Vanguard Fiduciary Trust Co | 28,437 | $211.3K | 0.00% | +28,437 | New |
| UBS Group AG | 37,061 | $275.4K | 0.00% | +36,697+10,081.6% | Added |
| Geode Capital Management, LLC | 49,975 | $371.5K | 0.00% | +2,234+4.7% | Added |
| LPL Financial LLC | 51,500 | $382.6K | 0.00% | −14,500−22.0% | Reduced |
| Citadel Advisors LLC | 54,311 | $403.5K | 0.00% | +2,477+4.8% | Added |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 76,247 | $566.5K | 0.03% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 83,055 | $617.1K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 100,450 | $746.3K | 0.00% | +15,006+17.6% | Added |
| SummitTX Capital, L.P. | 148,799 | $1.11M | 0.04% | +9,375+6.7% | Added |
| Woodline Partners LP | 177,362 | $1.32M | 0.00% | −111,807−38.7% | Reduced |
| Vanguard Capital Management LLC | 178,262 | $1.32M | 0.00% | +178,262 | New |
| Bank of America Corp | 229,754 | $1.71M | 0.00% | +216,646+1,652.8% | Added |
| Marshall Wace, LLP | 267,135 | $1.98M | 0.00% | −1,529−0.6% | Reduced |
| Sio Capital Management, LLC | 327,237 | $2.43M | 0.35% | −8,700−2.6% | Reduced |
| Alyeska Investment Group, L.P. | 412,000 | $3.06M | 0.01% | 00.0% | Unchanged |
| Deep Track Capital, LP | 444,110 | $3.30M | 0.07% | 00.0% | Unchanged |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −24,293−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −13,876−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −13,000−100.0% | Sold out |
| DRW Securities, LLC | 0 | $0 | 0.00% | −11,950−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −11,374−100.0% | Sold out |
| NorthCrest Asset Manangement, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −4,972−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Wealth Enhancement Advisory Services, LLC | 0 | $0 | 0.00% | 0 | Sold out |
| Triumph Capital Management | 0 | $0 | 0.00% | −135−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |